Physician
Nacogdoches Pulmonary and Sleep Associates PA
Nacogdoches Pulmonary and Sleep Associates PA was paid $1.65M by Medicaid between Jan 2018 and Dec 2024, across 52 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 38% of everything it billed.
33Billing provider infoNACOGDOCHES PULMONARY AND SLEEP ASSOCIATES PA
NACOGDOCHES, TX 75961
NACOGDOCHES, TX 75961
33aNPI1558699637assigned 11/30/2009
33bProvider typeCritical Care Medicine (Internal Medicine) Physician
28Total paid$1.65M
24GClaims93,147
24DCodes billed52
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Care Medicine (Internal Medicine) Physician providers in Texas
Rank by total paid#4 of 64
Median peer was paid$18K
This provider vs. median93×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,121 | $12K | |
| 2019 | 8,406 | $13K | |
| 2020 | 13,413 | $119K | |
| 2021 | 23,688 | $472K | |
| 2022 | 19,131 | $488K | |
| 2023 | 15,728 | $397K | |
| 2024incomplete | 4,660 | $152K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 38% | 19,218 | 17,230 | $628K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 17% | 581 | 577 | $281K |
| 94060 | 13% | 8,154 | 7,895 | $219K | |
| 94729 | 5.7% | 2,691 | 2,595 | $95K | |
| 94726 | 5.5% | 2,713 | 2,616 | $90K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 4.3% | 354 | 259 | $71K |
| 95811 | 3.8% | 132 | 131 | $63K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.3% | 685 | 661 | $54K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1.9% | 553 | 167 | $32K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.8% | 1,407 | 1,319 | $30K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 1.5% | 1,781 | 671 | $25K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 1.2% | 1,644 | 1,629 | $19K |
40 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 889 | $10K |
| 90756 | <1% | 521 | $10K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 558 | $6K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 123 | $4K |
| 90674 | <1% | 431 | $2K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 622 | $2K |
| 0011A | <1% | 149 | $2K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 495 | $2K |
| 99406 | <1% | 231 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 178 | $2K |
| 0012A | <1% | 72 | $1K | |
| 0013A | <1% | 94 | $1K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 27 | $578.70 |
| 99318 | <1% | 45 | $312.59 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 201 | $277.03 |
| 90661 | <1% | 12 | $195.51 | |
| 0031A | <1% | 17 | $144.79 | |
| 99407 | <1% | 14 | $109.10 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 165 | $36.74 |
| 91301 | <1% | 356 | $0.43 | |
| 91303 | <1% | 16 | $0.01 | |
| 4004F | 0% | 185 | $0.00 | |
| 4040F | 0% | 2,517 | $0.00 | |
| G8842 | Apnea hypopnea index (ahi), respiratory disturbance index (rdi) or respiratory event index (rei) documented or measured within 2 months after initial evaluation for suspected obstructive sleep apnea | 0% | 6,024 | $0.00 |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 399 | $0.00 |
| G9695 | Long-acting inhaled bronchodilator prescribed | 0% | 2,583 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 6,084 | $0.00 |
| G8845 | Positive airway pressure therapy prescribed | 0% | 4,863 | $0.00 |
| 3023F | 0% | 1,499 | $0.00 | |
| G8851 | Adherence to therapy was assessed at least annually through an objective informatics system or through self-reporting (if objective reporting is not available, documented) | 0% | 4,337 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 262 | $0.00 |
| G8854 | Documentation of reason(s) for not objectively reporting adherence to evidence-based therapy (e.g., patients who have been diagnosed with a terminal or advanced disease with an expected life span of less than 6 months, patients who decline therapy, patients who do not return for follow-up at least annually, patients unable to access/afford therapy, patient's insurance will not cover therapy) | 0% | 164 | $0.00 |
| G8852 | Positive airway pressure therapy was prescribed | 0% | 4,066 | $0.00 |
| G8846 | Moderate or severe obstructive sleep apnea (apnea hypopnea index (ahi) or respiratory disturbance index (rdi) of 15 or greater) | 0% | 5,997 | $0.00 |
| G8839 | Sleep apnea symptoms assessed, including presence or absence of snoring and daytime sleepiness | 0% | 4,879 | $0.00 |
| G8924 | Spirometry results documented (fev1/fvc < 70%) | 0% | 1,528 | $0.00 |
| 1036F | 0% | 1,508 | $0.00 | |
| G8849 | Documentation of reason(s) for not prescribing positive airway pressure therapy (e.g., patient unable to tolerate, alternative therapies use, patient declined, financial, insurance coverage) | 0% | 814 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 282 | $0.00 |
| 99441 | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHASHIM, AHAMMED (PRESIDENT)